Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in China / NCT06375447
Recruiting Observational

Intelligent Diagnosis and Treatment Model for Insomnia Disorder

NCT06375447 · tracked via the Priya Life Science China tracker
Sponsor
Xuanwu Hospital, Beijing
Phase
Observational
Started
2022-12-01
Last updated
2024-12-10

Condition(s) studied

Insomnia

Investigational drug(s) / intervention(s)

Routine clinical treatment

Routine clinical treatment: Routine clinical treatment is based on the latest international guidelines for insomnia.

Study summary

To establish a multicenter, multi-dimensional cohort on insomnia disorder and to develop an intelligent model for the diagnosis and treatment of insomnia disorder.

Eligibility

Sex
ALL
Min age
18 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. A complaint of insomnia; 2. Age between 18 and 75; 3. Able to fill out the scale on their own; 4. Agree to sign the informed consent to participate in the study and cooperate in completing the follow-up visit. Exclusion Criteria: 1.A current or history of comorbid Axis I psychiatric disorders.

Primary outcome measure(s)

  • The change of Pittsburgh Sleep Quality Index (PSQI) total scores from baseline to 3 months, 6 months, 12 months, 18 months, and 24 months. — Baseline, 3 months, 6 months, 12 months, 18 months, 24 months
    The PSQI consists of 7 factors ranging from 0 to 3 points, and the total score ranges from 0 to 21 with higher scores indicating poorer quality.

Trial sites (5)

FacilityCityRegionStatus
Xuanwu Hospital, Capital Medical University Beijing China Recruiting
Beijing Tiantan Hospital, Capital Medical University Beijing China Recruiting
The First Bethune Hospital of Jilin University Changchun China Not Yet Recruiting
West China Hospital, Sichuan University Chengdu China Recruiting
The Second Affiliated Hospital of Soochow University Suzhou China Not Yet Recruiting

More Xuanwu Hospital, Beijing trials in China

Clinical Outcome in Patients With INPH Recruiting
The New Clinical Registration Trial of Interventional Treatment for Patients with Symptomatic Intracranial Artery Stenosis Starting soon
Blood Pressure Variability in Non-hypertensive Patients With Ischemic Cerebrovascular Disease Recruiting
Evaluation of the Effect of Healthy Lifestyle Intervention for Patients With Mild Cognitive Impairment Starting soon
Effects of Relaxation Training and Stimulus Control in Chronic Insomnia Patients Recruiting

Other trials for the same condition

Ning Shen Dan Xiang Gao Fang for Heart-Kidney Disharmony Insomnia Starting soon
A Multicenter Observational Study of Lemborexant on Insomnia Patients With Psychiatric Disorders Recruiting
Adenosine A2a Receptor-Mediated Neuroinflammation in Remote Ischemic Conditioning for Post-Stroke Sleep Disorders Recruiting
A Study of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Insomnia During Pregnancy Active, not recruiting
Changes in Ciprofol Dosage in Patients With Insomnia Undergoing Intravenous Anesthesia Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06375447 on ClinicalTrials.gov ↗ ← All trials in China